Geneos Wealth Management’s Franklin Short Duration US Government ETF FTSD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14K Hold
155
– – ﹤0.01% 1912
2026
Q1
$14.1K Hold
155
– – ﹤0.01% 1896
2025
Q4
$14.1K Buy
155
+2
+1% +$182 ﹤0.01% 1859
2025
Q3
$13.9K Buy
153
+2
+1% +$182 ﹤0.01% 1851
2025
Q2
$13.7K Buy
151
+3
+2% +$272 ﹤0.01% 2193
2025
Q1
$13.4K Sell
148
-31
-17% -$2.81K ﹤0.01% 2131
2024
Q4
$16.2K Buy
179
+5
+3% +$452 ﹤0.01% 1832
2024
Q3
$15.9K Sell
174
-6
-3% -$544 ﹤0.01% 1647
2024
Q2
$16.2K Sell
180
-29
-14% -$2.6K ﹤0.01% 1404
2024
Q1
$18.8K Buy
209
+53
+34% +$4.77K ﹤0.01% 1373
2023
Q4
$14K Sell
156
-11
-7% -$983 ﹤0.01% 1461
2023
Q3
$14.9K Buy
+167
New +$14.9K ﹤0.01% 1460

Other funds holding FTSD

Geneos Wealth Management's FTSD Position: Q2 2026 in Review

Geneos Wealth Management held its Franklin Short Duration US Government ETF (FTSD) position steady in Q2 2026 at 155 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #1912.

Geneos Wealth Management first reported a position in FTSD in Q3 2023 and has held it in 12 quarters since. The position peaked at $18.8K in Q1 2024. 65 funds tracked by Wall St. Rank hold FTSD as of Q2 2026.

  • Geneos Wealth Management held 155 shares of Franklin Short Duration US Government ETF worth $14K as of Q2 2026.
  • Geneos Wealth Management left its Franklin Short Duration US Government ETF share count unchanged in Q2 2026.
  • Franklin Short Duration US Government ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1912 holding.
  • Geneos Wealth Management first reported a position in Franklin Short Duration US Government ETF in Q3 2023 and has held it in 12 quarters since.
  • Geneos Wealth Management's Franklin Short Duration US Government ETF position peaked at $18.8K in Q1 2024.
  • 65 funds tracked by Wall St. Rank held Franklin Short Duration US Government ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.